Coreceptor expression |
CD4+, CD8+, DN type-I NKT subsets |
CD4+, DN type-I NKT cell subsets |
type-I NKT cell cytokine profile |
Th2 cytokines: CD4+ > CD4-
|
Less pronounced dichotomy of type-I |
Th1 cytokines: CD4+ < CD4-
|
NKT cell cytokine production |
type-I NKT frequency (blood) |
Blood: <0.1–1% |
Blood: ∼1–2% |
NKT cell distribution |
Liver enriched for type-II NKT |
Liver enriched for type-I NKT cells |
Effects of α-GC injection |
No anti-tumor response |
Prevents tumor regression and metastasis |
No liver toxicity |
Liver toxicity |